Petah Tikva, Israel · Founded 2014 · Privately Held (backing)
Developer of a diabetes management system designed to optimize intensive insulin therapy. DreaMed is based in Petah Tikva, Israel and was founded in 2014. It has raised $9.5 million.
Last price · $/share
—
Implied valuation
—
Total raised
$9.5M
Last round
—
Cap table — not yet on record
DreaMed's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DreaMed with a free account
·Watch DreaMed: the Monday email on marks, rounds and moves
